Loading stock data…
Envista Holdings Corporation (NVST)
$27.02+0.06 (+0.22%)
After Hours$27.02+0.00 (+0.00%)· Last close Jun 29
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Envista Holdings Corporation in the Healthcare sector is trading at $27.02 with a market capitalization of $4.0B. Wall Street consensus targets $29.69 (13 analysts), implying a +9.9% move over the next 12 months. The stock is currently 11% below its 52-week high of $30.42, remaining 14.4% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +9.9% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $705.50M↓ | $750.60M↑ | $669.90M↓ | $682.10M↑ | $616.90M |
| Gross Profit | $390.10M↓ | $410.60M↑ | $370.20M | $369.90M↑ | $336.00M |
| Operating Income | $66.20M↓ | $93.00M↑ | $57.50M↑ | $46.30M↓ | $47.40M |
| Net Income | $38.70M↑ | $32.90M↑ | -$30.30M↓ | $26.40M↑ | $18.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Eq...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.01B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
2.20%
Volume
Today's trading volume
2.00M
Recent News
NVST Stock Rallies 37.1% in a Year: What's Behind the Drive?
Envista rises 37.1% in a year as new dental product launches, margin gains, acquisitions and a strong balance sheet fuel growth.
Here's Why You Should Retain NVST Stock in Your Portfolio for Now
Envista is expanding globally, launching new products and boosting margins, but can growth initiatives outweigh tariff, FX and China-related risks?
1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Avoid
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Why Is Envista (NVST) Down 5.9% Since Last Earnings Report?
Envista (NVST) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Stocks Under $50 That Concern Us
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.